Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis
BW Karlson, MK Palmer, SJ Nicholls… - European journal of …, 2016 - journals.sagepub.com
Background Achieving the greatest reduction in atherogenic lipoproteins requires the
optimum dose and potency of statin. Using data from the VOYAGER meta-analysis, we …
optimum dose and potency of statin. Using data from the VOYAGER meta-analysis, we …
[HTML][HTML] Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
U Laufs, B Karmann, D Pittrow - Clinical Research in Cardiology, 2016 - Springer
The use of atorvastatin is rapidly increasing among statins since the introduction of generics.
However, only limited data are available on its current use and the effectiveness outside of …
However, only limited data are available on its current use and the effectiveness outside of …
An update on the benefits and risks of rosuvastatin therapy
PP Toth - Postgraduate Medicine, 2014 - Taylor & Francis
Abstract Rosuvastatin is a 3–hydroxy–3–methylglutaryl coenzyme A reductase inhibitor
(statin) that reduces low–density lipoprotein cholesterol levels to the greatest extent of all …
(statin) that reduces low–density lipoprotein cholesterol levels to the greatest extent of all …
To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of …
BW Karlson, MK Palmer, SJ Nicholls, P Lundman… - Atherosclerosis, 2015 - Elsevier
Abstract Background The 2013 American College of Cardiology and American Heart
Association (ACC/AHA) guidelines identify four patient groups who benefit from moderate-or …
Association (ACC/AHA) guidelines identify four patient groups who benefit from moderate-or …
Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment …
RE Schmieder, ST Schmidt, T Riemer, R Dechend… - …, 2014 - Am Heart Assoc
The long-term relationship between 24-hour ambulatory blood pressure (ABP) and office BP
in patients on therapy is not well documented. From a registry we included all patients in …
in patients on therapy is not well documented. From a registry we included all patients in …
Comparison of efficacy, safety, and cost-effectiveness of various statins in dyslipidemic diabetic patients
Materials and Methods: This is a cohort, observational, population-based study conducted at
diabetic clinics of the Hamad Medical Hospital and Primary Health Care Centers (PHCC) …
diabetic clinics of the Hamad Medical Hospital and Primary Health Care Centers (PHCC) …
[HTML][HTML] The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (Emblica officinalis), walnut (Juglans regia), olive (Olea europaea) and …
MP Hermans, Y Dierckxsens, I Janssens… - Frontiers in …, 2023 - frontiersin.org
Background: Hyperlipidemia is associated with a higher rate of cardiovascular,
cerebrovascular, and peripheral vascular disease. Conventional drugs such as statins are …
cerebrovascular, and peripheral vascular disease. Conventional drugs such as statins are …
Are recent statin recommendations to employ fixed doses and abandon targets effective for treatment of hypercholesterolaemia? Investigation based on number …
Background Assessed by number needed to treat (NNT) to prevent one event, it was
previously shown that for those at similar atherosclerotic cardiovascular disease (CVD) risk …
previously shown that for those at similar atherosclerotic cardiovascular disease (CVD) risk …
Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgia
CT Muhindo, SA Ahn, MF Rousseau… - … therapies in medicine, 2017 - Elsevier
Cholesfytol®, a lipid-lowering dietary supplement with antioxidant and anti-atherosclerotic
properties, combines red yeast rice (RYR) and olive extract (5 mg hydroxytyrosol equivalent) …
properties, combines red yeast rice (RYR) and olive extract (5 mg hydroxytyrosol equivalent) …
Intensive statin therapy, used alone or in combination with ezetimibe, improves homocysteine level and lipid peroxidation to a similar degree in patients with coronary …
E Pytel, P Jackowska, G Chwatko… - Pharmacological …, 2016 - Springer
Background Increase in the concentration of homocysteine is one of the risks of
cardiovascular diseases. Coronary artery disease accompanied the increase of LDL …
cardiovascular diseases. Coronary artery disease accompanied the increase of LDL …